THOMPSON KIMBERLY KRAIG (CEO, CFO) sold 0.1% of their position (129.90K shares) of KRAIG BIOCRAFT LABORATORIES, INC. on the open market
Insider sale on the open market — a minor trim. Check remaining position size for full context.
S · 2 sales
Filed: 7/19/2022ACC: 0001493152-22-019832
DirectorOfficer10% Owner· CEO, CFO
Since Dec 2020
-129.90K
Net shares
Net seller
$0.00
Total acquired
2
Open market trades
0B · 2S
2
Total transactions
129.90K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−50K
Price / share
—
Trade value
—
% of position
0.0%
7/15/2022
201.89M→201.84M
Common Stock
Direct
Shares
−79.90K
Price / share
—
Trade value
—
% of position
0.0%
7/18/2022
201.84M→201.76M
Total
Net shares
−129.90K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/15/2022 | S · Sale | −50K | — | — | 0.0% | 201.89M | 201.84M |
| Common Stock Direct | 7/18/2022 | S · Sale | −79.90K | — | — | 0.0% | 201.84M | 201.76M |
| Total | −129.90K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported